Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
WUXI APPTEC Maintains Full-Yr Results Guidance for Now; US Tariff Impact Highly Uncertain
Recommend 12 Positive 15 Negative 12 |
||||
|
||||
|
In response to the news that the US will soon announce significant import tariffs on pharmaceuticals, Edward Hu, Vice Chairman and Global Chief Investment Officer of WUXI APPTEC (02359.HK), said that tariffs will definitely impact the company, but the extent of the impact is still highly uncertain, Chinese media reported. WUXI APPTEC will maintain its full-year results guidance for the time being, but it will also keep a close eye on the progress of tariff policies and their impact on the guidance, Hu added. The WuXi series thrived along with the broader market today (10th). WUXI APPTEC once peaked at $53.25. It last traded at $50.75, up 4.86%. WUXI BIO (02269.HK) also climbed to a peak of $20.45. It was last at $19.76, up 6.81%, on a volume of 76.4245 million shares, involving $1.514 billion. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
